Quest Diagnostics Total Assets 2010-2024 | DGX

Quest Diagnostics total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Quest Diagnostics total assets for the quarter ending March 31, 2024 were $13.954B, a 9.07% increase year-over-year.
  • Quest Diagnostics total assets for 2023 were $14.022B, a 9.23% increase from 2022.
  • Quest Diagnostics total assets for 2022 were $12.837B, a 5.69% decline from 2021.
  • Quest Diagnostics total assets for 2021 were $13.611B, a 2.96% decline from 2020.
Quest Diagnostics Annual Total Assets
(Millions of US $)
2023 $14,022
2022 $12,837
2021 $13,611
2020 $14,026
2019 $12,843
2018 $11,003
2017 $10,503
2016 $10,100
2015 $9,962
2014 $9,857
2013 $8,948
2012 $9,284
2011 $9,313
2010 $8,528
2009 $8,564
Quest Diagnostics Quarterly Total Assets
(Millions of US $)
2024-03-31 $13,954
2023-12-31 $14,022
2023-09-30 $13,482
2023-06-30 $13,425
2023-03-31 $12,794
2022-12-31 $12,837
2022-09-30 $13,223
2022-06-30 $13,312
2022-03-31 $13,442
2021-12-31 $13,611
2021-09-30 $13,572
2021-06-30 $12,861
2021-03-31 $13,931
2020-12-31 $14,026
2020-09-30 $14,143
2020-06-30 $12,990
2020-03-31 $12,049
2019-12-31 $12,843
2019-09-30 $12,019
2019-06-30 $11,760
2019-03-31 $11,937
2018-12-31 $11,003
2018-09-30 $10,986
2018-06-30 $10,747
2018-03-31 $10,695
2017-12-31 $10,503
2017-09-30 $10,439
2017-06-30 $10,171
2017-03-31 $10,109
2016-12-31 $10,100
2016-09-30 $10,173
2016-06-30 $10,109
2016-03-31 $10,097
2015-12-31 $9,962
2015-09-30 $10,074
2015-06-30 $9,720
2015-03-31 $10,613
2014-12-31 $9,857
2014-09-30 $9,801
2014-06-30 $9,757
2014-03-31 $9,550
2013-12-31 $8,948
2013-09-30 $8,928
2013-06-30 $9,036
2013-03-31 $9,306
2012-12-31 $9,284
2012-09-30 $9,319
2012-06-30 $9,393
2012-03-31 $9,451
2011-12-31 $9,313
2011-09-30 $9,326
2011-06-30 $9,431
2011-03-31 $9,225
2010-12-31 $8,528
2010-09-30 $8,459
2010-06-30 $8,482
2010-03-31 $8,516
2009-12-31 $8,564
2009-09-30 $8,366
2009-06-30 $8,211
2009-03-31 $8,347
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.369B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00